Novo Nordisk A/S, the maker of Ozempic, is investing 8.5 billion kroner ($1.2 billion) to construct a large factory in Denmark to address rising demand for its popular drugs. The new 40,000 square-meter (430,000 square-foot) facility will include production capabilities and a warehouse. Located near Odense, Denmark's third-largest city, this marks a completely new site for the pharmaceutical company. The investment underscores Novo Nordisk's commitment to scaling its production to meet global needs. The factory represents a significant expansion of the company's infrastructure. Continue here.
If you do need a website or your business needs a website, we’re here to bring your dreams to live. Contact us. We would give you the best in quality and the most affordable you would get on the market place. Enjoy our 100% refundable deals. You can’t loose let’s talk about your project.
Kindly reach out on WhatsApp directly and let’s make this decision your most important and best investment post 3 years.
Disclaimer: Full credit to the writer, and the associates.
